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E-mail address: jules.beekwilder@wur.nl (J. BeekwChicory (Cichorium intybus L.), which is known to have a variety of terpene-hydroxylating activities,
was screened for a P450 mono-oxygenase to convert (+)-valencene to (+)-nootkatone. A novel P450
cDNA was identiﬁed in a chicory root EST library. Co-expression of the enzyme with a valencene syn-
thase in yeast, led to formation of trans-nootkatol, cis-nootkatol and (+)-nootkatone. The novel
enzyme was also found to catalyse a three step conversion of germacrene A to germacra-
1(10),4,11(13)-trien-12-oic acid, indicating its involvement in chicory sesquiterpene lactone biosyn-
thesis. Likewise, amorpha-4,11-diene was converted to artemisinic acid. Surprisingly, the chicory
P450 has a different regio-speciﬁcity on (+)-valencene compared to germacrene A and amorpha-
4,11-diene.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Many sesquiterpenes are of signiﬁcant importance for the ﬂa-
vour and fragrance industry. Hydroxylation of these terpenes often
adds to their sensory properties, and is therefore an essential step
in the production of ﬂavour molecules. The regio- and stereoselec-
tive introduction of a hydroxyl group into an unactivated organic
compound by means of organic synthesis is still challenging [1].
For this reason, hydroxylating enzymes such as cytochrome P450
mono-oxygenases are considered as an alternative way to intro-
duce regioselective modiﬁcations [2] and have great potential for
application in the production of natural ﬂavour molecules.
(+)-Nootkatone is an important oxidised sesquiterpene for the
ﬂavour and fragrance industry. It has a characteristic grapefruit-
like ﬂavour and a low odour threshold [3]. Natural (+)-nootkatone
can be extracted from grapefruit [4]. Since grapefruit material is
limited on the world market, synthetic (+)-nootkatone producedal Societies. Published by Elsevier
tional, PO Box 619, 6708PD
ilder).from (+)-valencene is predominantly used in commercial applica-
tions, also for the ﬂavour market [5]. Chemical oxidation of valen-
cene requires the use of tert-butyl chromate [6], which is a
carcinogenic substance. Alternatively non-carcinogenic tert-butyl
peracetate [7] or tert-butyl hydroperoxide can be used which are
highly ﬂammable and corrosive compounds.
(+)-Nootkatone may also be produced from (+)-valencene via
biotechnological approaches in recombinant organisms using the
enzymes involved in its biosynthesis [5]. The biosynthetic route
to (+)-nootkatone in grapefruit has not been established experi-
mentally, but has been suggested to start from valencene on which
a regioselective allylic hydroxylation results in formation of
2-hydroxyvalencene (or nootkatol), followed by oxidation to (+)-
nootkatone [4,5].
Several enzymes have been reported to mediate oxidation of
(+)-valencene to (+)-nootkatone or to its precursor nootkatol. Engi-
neered cytochrome P450s from Pseudomonas putida and Bacillus
megaterium were shown to convert valencene into nootkatone
[8,9]. Recently, a (+)-valencene dioxygenase from Pleurotus sapidus
was demonstrated to have this activity. For plants, several cyto-
chrome P450 enzymes capable of oxidising valencene have been
described. The premnaspirodiene oxygenase from HyoscyamusB.V. Open access under the Elsevier OA license.
K. Cankar et al. / FEBS Letters 585 (2011) 178–182 179muticus [10] was shown to catalyse mono-oxygenation of (+)-val-
encene to nootkatol. Mutations in substrate recognition regions
of this enzyme further improved the catalytic efﬁciency of nootka-
tol formation [10]. De Kraker et al. describe oxidation of a number
of sesquiterpenes by a microsomal extract from taproot of Cichori-
um intybus (chicory), in which P450 enzymes are represented.
Among the sesquiterpene oleﬁns that were tested as substrate
were germacrene A, which is naturally present in chicory as pre-
cursor for the synthesis of bitter sesquiterpene lactones, but also
sesquiterpenes that do not occur in chicory root, such as amor-
pha-4,11-diene and (+)-valencene. In the case of (+)-valencene,
both trans-nootkatol and (+)-nootkatone were found as reaction
products [11]. Plant microsomal extracts, such as the chicory root
extract, likely contain a variety of P450 enzymes. The formation
of bitter sesquiterpene lactones in root tissue requires several oxy-
genation steps, at different regions of the sesquiterpene carbon
scaffold. Recently, a cytochrome P450 from chicory has been
cloned which catalyzes oxidation of germacrene A and amorpha-
4,11-diene at the allylic position C12 [12]. Our aim was to clone
a chicory cytochrome P450 which is capable of catalyzing the reg-
ioselective oxidation of (+)-valencene and which can be used for
the biotechnological production of (+)-nootkatone.2. Materials and methods
2.1. Isolation and cloning of P450 gene from chicory
An expressed sequence tag (EST) database of a cDNA library de-
rived from the taproot of chicory was produced using the Roche
454 sequencing platform. Sequences were assembled using an in-
house bioinformatics facility and candidate P450s contigs were
identiﬁed by sequence homology to known sesquiterpene hydrox-
ylases. RACE PCR (Clontech) was used to obtain the sequence of the
50-region of the candidate contig 28771.
The full length genewas ampliﬁed from chicory cDNA using high
ﬁdelity Phusion polymerase (Finnzymes) with the addition of NotI
and PacI restriction sites and was subsequently cloned to pGEM-T
Easy (Promega). Three individual clones were fully sequenced
showing no sequence variation. The deduced protein sequence
was aligned with germacrene A oxidase (acc. no. GU256644) [12],
premnaspirodiene oxygenase (acc. no. EF569601) [10] and amor-
pha-4,11-diene oxidase (acc. no. DQ315671) [13,14] using Clustal
W [15]. The sequence of the gene was deposited in the NCBI Gen-
Bank Nucleotide database under accession number HQ166835.
The sequence was also submitted to David Nelson’s cytochrome
P450 homepage (http://drnelson.uthsc.edu/cytochromeP450.html)
and was assigned the name CYP71AV8 [16].2.2. Co-expression of CYP71AV8 with terpene synthases in yeast
The full length gene was re-cloned, using the NotI/PacI restric-
tion sites, into the yeast expression vector pYEDP60 [17] which
was modiﬁed to contain PacI and NotI sites at the polylinker. The
candidate chicory P450 was co-transformed with either a germac-
rene A synthase [18], amorpha-4,11-diene synthase [14] or a val-
encene synthase [19] into the into yeast strain WAT 11
expressing Arabidopsis ATR1 NADPH-cytochrome P450 reductase
[20]. Germacrene A synthase was cloned into pYEDP80 vector
[17] with TRP1 auxotrophic selection marker using BamHI and
EcoRI restriction sites. Amorpha-4,11-diene synthase and valen-
cene synthase were both cloned into pYES3/CT yeast expression
vector (Invitrogen) with TRP1 selection marker using BamHI and
NotI restriction sites. No terminal tags were added in these con-
structs. After transformation yeast clones containing the chicory
P450 and terpene synthases were selected on Synthetic Dextroseminimal medium (0.67% Difco yeast nitrogen base medium with-
out amino acids, 2% D-glucose, 2% agar) supplemented with amino
acids, but omitting uracil, adenine sulphate and L-tryptophane for
auxotrophic selection of transformants.
A starter yeast culture was grown overnight at 30 C in 5 ml of
Synthetic Galactose minimal medium (0.67% Difco yeast nitrogen
base medium without amino acids, 2% D-galactose, amino acids,
but omitting uracil, adenine sulphate and L-tryptophane), The star-
ter culture was diluted to OD600 of 0.05 in 50 ml of Synthetic Gal-
actose minimal medium and incubated at 200 rpm at 30 C. The
culture was overlaid with 5 ml of n-dodecane [21] when the
OD600 was in the range from 0.8 to 1 and cultivation was continued
for 3 days. The n-dodecane layer was collected and centrifuged at
1200 rpm for 10 min, diluted threefold in ethyl acetate, dried using
anhydrous Na2SO4 and then used for GC–MS analysis. In co-expres-
sion experiments with amorpha-4,11-diene synthase and germac-
rene A synthase 7 ml of the yeast culture was further extracted
three times with 2 ml ethyl acetate, concentrated, dehydrated
using anhydrous Na2SO4 and used for GC-MS analysis. For analysis
of artemisinic acid and germacra-1(10),4,11(13)-trien-12-oic acid,
samples were ﬁrst methylated using diazomethane.
2.3. GC-MS analysis
Analytes from 1 lL samples were separated using a gas chro-
matograph (5890 series II, Hewlett-Packard) equipped with a
30 m  0.25 mm, 0.25 mm ﬁlm thickness column (ZB-5, Phenome-
nex) using helium as carrier gas at ﬂow rate of 1 ml/min. The injec-
tor was used in splitless mode with the inlet temperature set to
250 C. The initial oven temperature of 45 C was increased after
1 min to 300 C at a rate of 10 C/min and held for 5 min at
300 C. The GC was coupled to a mass-selective detector (model
5972A, Hewlett-Packard). Compounds were identiﬁed by
comparison of mass spectra and retention times (rt) with those
of the following authentic standards: germacrene A, germacra-
1(10),4,11(13)-trien-12-ol, germacra-1(10),4,11 (13)-trien-12-al
[11], amorpha-4,11-diene, artemisinic alcohol, dihydroartemisinic
alcohol, artemisinic aldehyde, artemisinic acid [22], (+)-valencene,
trans-nootkatol, cis-nootkatol (Isobionics) and (+)-nootkatone
(Fluka). Quantiﬁcation of sesquiterpenes was conducted by deter-
mination of total ion count (TIC) peak area of the sesquiterpene
peaks from three independent fermentation experiments. Absolute
concentration of sesquiterpenes was calculated from the peak area
by comparison to a standard curve prepared by measuring a
dilution series of authentic standards with known concentrations.3. Results
3.1. Isolation of a novel P450 gene from chicory
A cDNA library was created from root tissue of C. intybus. This
library was analyzed by sequencing using the Roche 454 sequenc-
ing platform, which resulted in 575 945 EST sequences of on aver-
age 400 bp in size. By sequence assembly, 40 847 contigs were
formed from which 31 787 singletons remained.
The sequences were combined with 35 973 C. intybus EST se-
quences from GenBank, and interrogated for sequences with
homology to the cytochrome P450 sequences of premnaspirodiene
oxygenase from H. muticus [10] and amorpha-4,11-diene oxidase
from Artemisia annua [13,14]. Two sequences with high similarity
to both genes were identiﬁed, one of which encoded the recently
described C. intybus germacrene A oxidase [12]. The second se-
quence encodes a novel protein CYP71AV8 with 50% sequence
identity to premnaspirodiene oxygenase, 78% to amorpha-4,11-
diene oxidase and 81% to the germacrene A oxidase from C. intybus.
Table 1
Quantiﬁcation of valencene-derived products in the n-dodecane layer after yeast
fermentation.
Enzymes expressed Products Quantity mg/l yeast culture
(mean ± S.D., n = 3)
VS (+)-valencene 1.36 ± 0.05
VS + CYP71AV8 (+)-valencene 0.15 ± 0.02
trans-nootkatol 0.92 ± 0.07
cis-nootkatol 0.11 ± 0.03
(+)-nootkatone 0.04 ± 0.00
VS = valencene synthase.
Fig. 1. GC-MS analysis of in vivo hydroxylation of (+)-valencene by CYP71AV8 to nootka
WAT11 producing (+)-valencene (1) is compared to (b) the yeast strain WAT11 expressing
nootkatol (2), trans-nootkatol (3) and trace amounts of (+)-nootkatone (4). Inserts in the c
y-axis scales of the chromatograms are identical. Mass spectra for (+)-nootkatone (c), cis-
nootkatol (f) and trans-nootkatol (h) standards are shown.
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nootkatone in vivo
To assess its value in a biotechnological production platform, the
activity of CYP71AV8 on (+)-valencene was tested by co-expression
of the enzyme with a valencene synthase in yeast. In yeast cultures
co-expressing valencene synthase and CYP71AV8 the majority of
(+)-valencene had disappeared compared to control cultures with-
out P450 (Table 1). As novel product, the predominant peak was
identiﬁed as trans-nootkatol (rt = 16.53 min). A smaller peak of
cis-nootkatol was detected (rt = 16.36 min) (Fig. 1). At a retention
time of 17.51 min a small peak of (+)-nootkatone was detected. Atol and (+)-nootkatone. Chromatogram of the n-dodecane layer from (a) yeast strain
valencene synthase and CYP71AV8 where (+)-valencene (1) is transformed into cis-
hromatograms zoom in on the region of 17.2 to 17.7 min of the chromatograms. The
nootkatol (e) and trans-nootkatol (g) produced by yeast and (+)-nootkatone (d), cis-
Fig. 2. GC–MS analysis of the germacrene A oxidation by CYP71AV8. Co-expression
of chicory germacrene A synthase and the CYP71AV8 led to conversion of (1)
germacrene A, to (2) germacra-1(10),4,11(13)-trien-12-al, (3) germacra-
1(10),4,11(13)-trien-12-ol and (4) germacra-1(10),4,11(13)-trien-12-oic acid. (a)
Chromatogram of the n-dodecane layer of yeast expressing germacrene A synthase;
(b) Chromatogram of the n-dodecane layer expressing germacrene A synthase and
CYP71AV8; (c) chromatogram of ethyl acetate extract of yeast expressing germac-
rene A synthase and CYP71AV8.
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was also detected (rt = 16.11). Thus it appeared that CYP71AV8 is a
valencene oxidase, which preferentially hydroxylates the C2 posi-
tion of (+)-valencene in the trans-orientation. A small portion of
nootkatol is further oxidised to (+)-nootkatone.
3.3. Activity of CYP71AV8 on other sesquiterpenes
To further assess the substrate speciﬁcity in vivo, the CYP71AV8
was also introduced into yeast strains expressing either germac-
rene A synthase or amorpha-4,11-diene synthase. Upon co-expres-
sion of CYP71AV8 with germacrene A synthase, germacrene
A accumulation in the n-dodecane layer decreased, while the
prevalent novel product was identiﬁed as germacra-1(10),4,
11(13)-trien-12-al, and a smaller peak of germacra-1(10),4,11
(13)-trien-12-ol (Fig. 2). In the ethylacetate extract of the yeast cul-
ture germacra-1(10),4,11(13)-trien-12-oic acid was detected after
methylation with diazomethane. This suggests that CYP71AV8
catalyzes a three-step conversion of germacrene A to germacra-
1(10),4,11(13)-trien-12-oic acid, as was previously shown for the
chicory germacrene A oxidase [12].
Co-expression of amorpha-4,11-diene synthase with CYP71AV8
led to partial conversion of produced amorpha-4,11-diene into
artemisinic alcohol and artemisinic aldehyde. In addition, small
amounts of artemisinic acid and dihydroartemisinic aldehyde were
observed. Thus CYP71AV8 can also function as a germacrene Aoxidase and an amorpha-4,11-diene oxidase, which preferentially
hydroxylates at the allylic C12 position of germacrene A and amor-
pha-4,11-diene, and can further oxidise the allylic hydroxyl groups
into carboxylic acids.
4. Discussion
In this work, we describe a novel P450 enzyme from chicory,
which can oxidise (+)-valencene at the C2 position, leading to
(+)-nootkatone formation. It is the ﬁrst P450 enzyme that has been
demonstrated to be functional in an in vivo production system of
valencene-based ﬂavour compounds. Upon expression of CY-
P71AV8 in a valencene producing yeast strain 68% of the (+)-valen-
cene was oxidised to trans-nootkatol, 8% to cis-nootkatol and 3% to
(+)-nootkatone (Table 1). It is unclear whether the production of
(+)-nootkatone results from the activity of CYP71AV8 or the unspe-
ciﬁc alcohol dehydrogenase activity present in yeast. The yields of
(+)-nootkatone produced per liter yeast culture are still modest.
This likely results from the poor production of (+)-valencene and
other precursors. Extensive engineering of yeast producing artem-
isinic acid resulted in production levels of up to 100 mg/L culture
[13].
Surprisingly, the same enzyme which oxidises the C2 position
in (+)-valencene, also oxidises at the C12 position, when amor-
pha-4,11-diene or germacrene are supplied as substrates (Fig. 3).
This observation may provide novel insights in the regiospeciﬁcity
of plant P450 enzymes. One of the few reports discussing factors
affecting regiospeciﬁcity is the pioneering work of Takahashi
et al. [10] The authors characterized H. muticus premnaspirodiene
oxygenase, which introduces an oxygen exclusively in the C2 reg-
ioposition of the A ring of both spirodecanes (e.g. premnaspirodi-
ene) and eremophilanes (5-epi-aristolochene, epi-eremophilene
and (+)-valencene). In the recently published work by Nguyen
et al. [12], the chicory germacrene A oxidase is shown to selectively
oxidise at the C12 position of both germacrene A and amorpha-
4,11-diene. Thus it would seem that two categories of sesquiter-
pene modifying P450 enzymes can be distinguished in the plant
kingdom: those that act on the A-ring, such as the H. muticus
premnaspirodiene oxygenase, and those that act on the allylic
C12 position, such as the chicory germacrene A oxidase and the
A. annua amorpha-4,11-diene oxidase. Therefore, ﬁnding that a sin-
gle P450 can oxidise different regio-positions on such structurally
related molecules as germacrene A and (+)-valencene was
unexpected.
In the past, De Kraker at al. [11], reported that a microsomal ex-
tract of chicory could indeed perform both regiospeciﬁc reactions.
In the latter work, it was postulated that chicory germacrene A oxi-
dase also mediates C-12 oxidation of amorpha-4,11-diene, but that
the formation of (+)-nootkatone is catalyzed by a different mono-
oxygenase. This latter mono-oxygenase would possibly catalyse a
later step in bitter sesquiterpene lactone biosynthesis, the conver-
sion of costunolide into leucodin. Notably, the authors describe
that formation of (+)-nootkatone was inhibited up to 90% by the
addition of germacrene A, an effect which would not be in accor-
dance with their two-enzyme hypothesis, but is in accordance with
a single cytochrome P450 mediating both (+)-valencene to (+)-noo-
tkatone conversion, as well as germacrene A to germacra-
1(10),4,11(13)-trien-12-oic acid conversion. Still, this leaves open
the question why two different positions on the sesquiterpene car-
bon scaffold can be oxidised by the same enzyme. Likely this is the
result of a different orientation of (+)-valencene on one hand, and
germacrene A and amorpha-4,11-diene on the other hand, in the
substrate binding pocket of the P450 enzyme.
Regiospeciﬁcity of P450 enzymes is important for the produc-
tion of ﬁne chemicals. This work clearly shows that regiospeciﬁcity
of plant P450 enzymes is poorly predictable from the carbon atom
Fig. 3. Reactions catalyzed by CYP71AV8. CYP71AV8 catalyses (A) conversion of (+)-valencene to (+)-nootkatone via trans- and cis- nootkatol, (B) a three-step conversion of
germacrene A to germacra-1(10),4,11(13)-trien-12-oic acid, and (C) a three step conversion of amorpha-4,11-diene to artemisinic acid. The preferred position of
hydroxylation is marked in bold.
182 K. Cankar et al. / FEBS Letters 585 (2011) 178–182numbering (Fig. 3), which is based on the numbering of the general
sesquiterpene precursor farnesyl diphosphate. More knowledge of
the three-dimensional properties of the substrate-binding pocket
of the P450 enzyme, in addition to more extensive variation of sub-
strates, is needed to fully understand P450 regiospeciﬁcity.
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